Work

Metformin and lung cancer

Year: 2014

Type: article

Abstract: Metformin, a commonly used anti-diabetic drug has emerged as a potential anti-cancer drug.Over the last few years, a mass of epidemiologic, outcomes and preclinical data has emerged demonstratic the potential clinical relevance and the mechanistic basis of the anti-cancer activity of this well tolerated drug in lung cancer.This review article summarizes this evidence that supports the trial of this drug in in lung cancer.

Source: The Journal of Clinical and Scientific Research

DOI: 10.4103/2277-5706.241578

Author: Sai Yendamuri

Institution: Roswell Park Comprehensive Cancer Center

Language: English

Topic: Metabolism, Diabetes, and Cancer

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: diamond

OpenAlex ID: W2316530995

FWCI:

Cites: 29

Cited by: 1

Related to: 10